These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 7852485)

  • 21. Identification of a subgroup of Graves' disease patients at higher risk for severe ophthalmopathy after radioiodine.
    Barth A; Probst P; Bürgi H
    J Endocrinol Invest; 1991 Mar; 14(3):209-12. PubMed ID: 2071823
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Preventing Graves' ophthalmopathy.
    Wiersinga WM
    N Engl J Med; 1998 Jan; 338(2):121-2. PubMed ID: 9420345
    [No Abstract]   [Full Text] [Related]  

  • 23. Graves' disease and thyroid associated ophthalmopathy following radioiodine therapy in euthyroid multinodular goiter.
    Munigoti S; Samat A; Keston Jones M
    Thyroid; 2008 May; 18(5):585. PubMed ID: 18466082
    [No Abstract]   [Full Text] [Related]  

  • 24. Do glucocorticoids affect outcome in Graves' disease following radioiodine therapy?
    Salvatore D; Fenzi G
    Nat Clin Pract Endocrinol Metab; 2006 Apr; 2(4):194-5. PubMed ID: 16932282
    [No Abstract]   [Full Text] [Related]  

  • 25. Development of Graves' ophthalmopathy and uveitis after radioiodine therapy for Graves' disease in a patient with HTLV-I associated myelopathy (HAM).
    Ozawa Y; Migita M; Watanabe T; Okuda I; Takeshita A; Takagi A; Shishiba Y
    Intern Med; 1994 Sep; 33(9):564-8. PubMed ID: 8000111
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Radioactive iodine therapy in Graves' hyperthyroidism.
    Sankar R; Sripathy G
    Natl Med J India; 2000; 13(5):246-51. PubMed ID: 11190053
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Radioiodine treatment of Graves' disease --for its wider indication and application in Japan].
    Konishi J
    Nihon Rinsho; 2006 Dec; 64(12):2257-61. PubMed ID: 17154088
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Airway complication occurring during radioiodine treatment for Graves' disease.
    Kinuya S; Yoneyama T; Michigishi T
    Ann Nucl Med; 2007 Aug; 21(6):367-9. PubMed ID: 17705018
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neonatal hyperthyroidism in the offspring of mothers with Graves' disease treated with radioiodine.
    García García E; Porras Cantarero JA; Fernández López P; Domínguez Gutiérrez de Ceballos R; Domínguez Pascual I
    Endocrinol Nutr; 2013 Nov; 60(9):e31-2. PubMed ID: 23490308
    [No Abstract]   [Full Text] [Related]  

  • 30. Radioiodine therapy compared in patients with toxic nodular or Graves' hyperthyroidism.
    Franklyn JA; Daykin J; Holder R; Sheppard MC
    QJM; 1995 Mar; 88(3):175-80. PubMed ID: 7767667
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Graves' hyperthyroidism: treatment with antithyroid drugs, surgery, or radioiodine--a prospective, randomized study. Thyroid Study Group.
    Törring O; Tallstedt L; Wallin G; Lundell G; Ljunggren JG; Taube A; Sääf M; Hamberger B
    J Clin Endocrinol Metab; 1996 Aug; 81(8):2986-93. PubMed ID: 8768863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Radioiodine treatment of Graves' disease. An assessment of its potential risks.
    Graham GD; Burman KD
    Ann Intern Med; 1986 Dec; 105(6):900-5. PubMed ID: 3777715
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment with iodine radioisotopes and thyroid-associated ophthalmopathy in Graves' disease].
    Rasmussen AK; Feldt-Rasmussen UF
    Ugeskr Laeger; 1999 Oct; 161(43):5933-4. PubMed ID: 10778332
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical review 99: The management of Graves' disease in children, with special emphasis on radioiodine treatment.
    Rivkees SA; Sklar C; Freemark M
    J Clin Endocrinol Metab; 1998 Nov; 83(11):3767-76. PubMed ID: 9814445
    [No Abstract]   [Full Text] [Related]  

  • 35. [Long-term results of radioiodine (131I) treatment in 331 patients with Graves' disease (author's transl)].
    Saito S; Sakurada T; Yamamoto M; Yoshida K; Kaise K; Kaise N; Yoshinaga K
    Nihon Naika Gakkai Zasshi; 1979 Jul; 68(7):724-32. PubMed ID: 113472
    [No Abstract]   [Full Text] [Related]  

  • 36. [Radioiodine versus surgery in the treatment of Graves' hyperthyroidism].
    Jukić T; Stanicić J; Petric V; Kusić Z
    Lijec Vjesn; 2010; 132(11-12):355-60. PubMed ID: 21294325
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Radioiodine therapy of Graves' disease--quality assurance and radiation protection].
    Reiners C
    Z Arztl Fortbild Qualitatssich; 1999 Apr; 93 Suppl 1():61-6. PubMed ID: 10355053
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Graves' ophthalmopathy after subtotal thyroidectomy and radioiodine therapy.
    Fernández Sánchez JR; Rosell Pradas J; Carazo Martinez O; Torres Vela E; Escobar Jimenez F; Garbin Fuentes I; Vara Thorbeck R
    Br J Surg; 1993 Sep; 80(9):1134-6. PubMed ID: 8402112
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Radioiodine therapy for women with Graves' disease and the risk of foetal hypothyroidism if they are later found to be pregnant].
    Prinsen AK; Jansen J; Bakker WH; Wildschut HI
    Ned Tijdschr Geneeskd; 2006 Dec; 150(52):2845-8. PubMed ID: 17319213
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Thyroid remnant radioiodine ablation in a case of concurrent thyroid carcinoma, Graves' disease, and thyroid ophthalmopathy.
    Mansberg R
    Clin Nucl Med; 2007 Jul; 32(7):513-5. PubMed ID: 17581332
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.